300+ peer-reviewed scientific publications
More than 500 HTA & PRISMA- compliant evidence synthesis, Health Economics modeling and medical writing projects delivered.
50+ submissions supported
300+ peer-reviewed scientific publications
Established in 2020, Pharmacoevidence has grown into a recognized leader in pharmaceutical research, guided by a steadfast focus on innovation and patient well‑
Pharmacoevidence’s Generative AI Products empower life sciences organizations to generate high-quality evidence with speed and precision. From automated SLRs to HTA review simulations, our intelligent platforms minimize manual effort, enhance analytical accuracy, and support strategic market access decisions.
